AzTrials
AzTrials

Eosinophilic EsophagitisNCT05755477

Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE Exacerbations

An observational study of Eosinophilic Esophagitis and Respiratory Allergy, run by Nucera Eleonora at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Eosinophilic esophagitis (EoE) is a chronic inflammatory esophagus disease that is presented in patients with a history of recurrent dysphagia. EoE is closely related to other pathologies with an immuno-allergic etiopathogenesis such as atopic dermatitis (AD), IgE-mediated food allergy, allergic rhinitis and bronchial… Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Eosinophilic Esophagitis, Respiratory Allergy
How many people
30 participants
Where
1 siteItaly
Study dates
3 Jan 2021to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Adult, Older adult

Study population: All the subjects (both sex) between 18 and 75 years old with EOE diagnosis

Who may be able to join

  • All the subjects with EOE diagnosis

Who cannot join

  • All the patients without EOE diagnosis

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma, 00168

    Arianna Aruanno, MD, PhD, 393282190241, arianna.aruanno@policlinicogemelli.it

    Recruiting

Other trials in Italy

About this study

Official title: Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE Exacerbations: the Role of Respiratory Allergy in the EOE Etiopathogenesis

Eosinophilic esophagitis (EoE) is a chronic inflammatory esophagus disease that is presented in patients with a history of recurrent dysphagia.

EoE is closely related to other pathologies with an immuno-allergic etiopathogenesis such as atopic dermatitis (AD), IgE-mediated food allergy, allergic rhinitis and bronchial asthma.

Read more

While the importance of the correlation between diet and food allergy has been largely demonstrated, less is known about the exact role of sensitization to aerollergens in the progression and recrudescence of symptoms.

In support of this correlation there is evidence of a seasonal trend in the new diagnoses of EoE, of the possibility of the de-novo onset of the pathology following massive exposure to a specific aeroallergen and the demonstration that the degree of esophageal eosinophilia varies according to the climatic zone and the season of the year.

The detailed knowledge of this correlation could clarify some aspects of the etiopathogenesis and natural history of EoE, improve and personalize the clinical-diagnostic management of affected patients and provide new therapeutic targets.

Our aim is evaluating the possible existence of a correlation between the recrudescence of dysphagia symptoms and a specific month of the year and/or specific season.

Read the detailed description

Eosinophilic esophagitis (EoE) is a chronic inflammatory esophagus disease that is presented in patients with a history of recurrent dysphagia.

EoE is closely related to other pathologies with an immuno-allergic etiopathogenesis such as atopic dermatitis (AD), IgE-mediated food allergy, allergic rhinitis and bronchial asthma.

While the importance of the correlation between diet and food allergy has been largely demonstrated, less is known about the exact role of sensitization to aerollergens in the progression and recrudescence of symptoms.

In support of this correlation there is evidence of a seasonal trend in the new diagnoses of EoE, of the possibility of the de-novo onset of the pathology following massive exposure to a specific aeroallergen and the demonstration that the degree of esophageal eosinophilia varies according to the climatic zone and the season of the year.

The detailed knowledge of this correlation could clarify some aspects of the etiopathogenesis and natural history of EoE, improve and personalize the clinical-diagnostic management of affected patients and provide new therapeutic targets.

It is a cross-sectional observational study and the aim is:

  • evaluating the possible existence of a correlation between the recrudescence of dysphagia symptoms and a specific month of the year and/or specific season
  • evaluating whether there is a statistically significant correlation between the anamnestic onset of the disease and the individual patient's sensitization to aeroallergens and the prevalence of respiratory allergy (rhinitis and allergic asthma) in patients with EoE.

All the patient should answer a questionnaire about the state of health over the year and according to the various pollen seasons

The questionnaire is made up of 18 questions which aim to investigate:

  • anamnestic data (age, weight, height, clinical onset of the pathology);
  • dysphagia symptomatology through modified DSQ (Dysphagia Symptom Questionnaire);
  • rhinitis symptomatology SFAR (Score For Allergic Rhinitis);
  • trend of exacerbations of dysphagia symptoms in the different months of the year.

The aforementioned data aim to investigate the rhinitis and dysphagia symptoms of the patients in the last 12 months.

Medical subject headings
Eosinophilic Esophagitis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation between the recrudescence of dysphagia symptoms and Seasons

    Evaluate the possible correlation between the recrudescence of dysphagia symptoms and a specific month of the year and/or specific season.

    Measured: 12 months

Secondary outcomes (2)
  1. Correlation between the anamnestic onset of the disease and the individual patient's sensitization to aeroallergens.

    Evaluate whether there is a statistically significant correlation between the anamnestic onset of the disease and the individual patient's sensitization to aeroallergens.

    Measured: 12 months

  2. Prevalence of respiratory allergy (rhinitis and allergic asthma) in patients with EoE.

    Evaluate the prevalence of respiratory allergy (rhinitis and allergic asthma) in patients with EoE.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2023
  2. Study start3 Jan 2021
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05755477
Sponsor's protocol ID
3638
Status last verified
Mar 2023
First submitted
21 Feb 2023
Last updated
6 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Eosinophilic Esophagitis and Respiratory Allergy, run by Nucera Eleonora at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eleonora NUCERA, PROF. (390630154965, eleonora.nucera@policlinicogemelli.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation between the recrudescence of dysphagia symptoms and Seasons (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in